• LAST PRICE
    61.0400
  • TODAY'S CHANGE (%)
    Trending Down-0.8700 (-1.4053%)
  • Bid / Lots
    60.0800/ 10
  • Ask / Lots
    62.5800/ 5
  • Open / Previous Close
    61.8900 / 61.9100
  • Day Range
    Low 60.5500
    High 62.2200
  • 52 Week Range
    Low 42.2100
    High 76.9800
  • Volume
    277,831
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 61.91
TimeVolumeIMCR
09:32 ET84061.4675
09:36 ET40062.15
09:38 ET10061.95
09:39 ET70062.08
09:41 ET40061.95
09:45 ET69761.955
09:48 ET200061.97
09:50 ET10062.12
09:57 ET20061.83
09:59 ET202561.45
10:01 ET29561.61
10:10 ET10061.405
10:14 ET240061.53
10:15 ET45061.53
10:19 ET10061.24
10:21 ET10061.06
10:24 ET20061.16
10:26 ET100261.125
10:28 ET108161.07
10:30 ET30061.12
10:32 ET10060.995
10:33 ET120061.09
10:35 ET10060.945
10:37 ET10061
10:39 ET10061.17
10:42 ET50060.965
10:44 ET20060.89
10:46 ET10061
10:48 ET10060.99
10:50 ET30061
10:53 ET40061.19
10:55 ET10061.115
10:57 ET10061.29
11:04 ET10061.53
11:06 ET60061.5625
11:08 ET92561.92
11:09 ET10062.01
11:15 ET830061.94
11:18 ET68161.77
11:22 ET10061.61
11:24 ET50061.43
11:26 ET10061.43
11:29 ET10061.43
11:31 ET70061.59
11:38 ET20061.665
11:42 ET104261.78
11:54 ET95861.74
11:56 ET10061.665
11:58 ET30061.58
12:00 ET10061.57
12:05 ET10061.565
12:07 ET10061.55
12:09 ET60061.68
12:21 ET10020061.72
12:23 ET150061.68
12:25 ET60061.83
12:34 ET50061.84
12:36 ET40061.97
12:39 ET70062
12:41 ET40061.855
12:43 ET10061.76
12:45 ET20061.73
12:48 ET10061.6
12:50 ET20061.585
12:52 ET70061.77
12:59 ET10061.8
01:01 ET90061.64
01:03 ET2500061.65
01:08 ET30061.63
01:10 ET50061.45
01:12 ET10061.36
01:14 ET30061.445
01:15 ET159961.62
01:17 ET60561.68
01:24 ET30061.575
01:26 ET49161.57
01:30 ET10061.61
01:32 ET110061.39
01:37 ET70061.36
01:39 ET233761.07
01:42 ET50061.065
01:44 ET35060.95
01:46 ET35060.79
01:50 ET20060.86
01:51 ET30360.78
01:55 ET60060.76
01:57 ET140060.85
02:00 ET30060.905
02:02 ET55060.725
02:08 ET40060.6
02:11 ET42560.55
02:13 ET368560.84
02:18 ET50060.96
02:22 ET140561.11
02:24 ET131161.045
02:27 ET50061
02:29 ET50061.15
02:33 ET40061.27
02:38 ET40061.13
02:42 ET10061.145
02:44 ET10061.1
02:45 ET10061.11
02:47 ET50061.1425
02:51 ET10061.14
02:54 ET109761.105
02:58 ET40060.915
03:00 ET50060.96
03:05 ET30060.85
03:09 ET90060.975
03:14 ET10061.055
03:18 ET30061.0733
03:21 ET32560.9931
03:23 ET10060.99
03:25 ET232161
03:30 ET15061.175
03:34 ET30061.21
03:36 ET169961.15
03:39 ET20061.13
03:41 ET61761.07
03:43 ET40061.04
03:45 ET24361.055
03:48 ET105061.1
03:50 ET193161.05
03:52 ET10061.06
03:54 ET208561.13
03:56 ET140061.05
03:57 ET433261.06
03:59 ET503861.04
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMCR
Immunocore Holdings PLC
3.1B
-54.0x
---
United StatesCORT
Corcept Therapeutics Inc
2.5B
22.9x
+9.80%
United StatesLGND
Ligand Pharmaceuticals Inc
1.3B
25.2x
-12.71%
United StatesINVA
Innoviva Inc
965.9M
6.9x
-9.89%
United StatesAVDL
Avadel Pharmaceuticals PLC
1.8B
-8.9x
---
United StatesEOLS
Evolus Inc
821.8M
-12.4x
---
As of 2024-05-08

Company Information

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters
90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone
123-543-8600
Fax
---

Executives

Independent Chairman of the Board
John Bell
Chief Executive Officer, Director
Bahija Jallal
Chief Financial Officer, Head of Strategy
Brian Di Donato
Chief Human Resource Officer
Tina St Leger
Head of Research and Development
David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.1B
Revenue (TTM)
$249.4M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.13
Book Value
$7.42
P/E Ratio
-54.0x
Price/Sales (TTM)
12.4
Price/Cash Flow (TTM)
---
Operating Margin
-23.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.